Fibrovascular Changes Misdiagnosed as Cytomegalovirus Retinitis Reactivation in a Patient with Immune Recovery

Clinical Infectious Diseases

Volumn 38, Issue 1, 2004, Pages 139-141

  Robinson, Michael R ^a   Csaky, Karl G ^a   Lee, Susan S ^a   Masur, Henry ^b   Polis, Michael A ^b  

^a NATIONAL EYE INSTITUTE   (United States)

^b NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CIDOFOVIR; DEXAMETHASONE SODIUM PHOSPHATE; DIDANOSINE; FOSCARNET; GANCICLOVIR; KETOROLAC TROMETAMOL; LAMIVUDINE; PREDNISOLONE ACETATE; STAVUDINE;

ADULT; ARTICLE; CASE REPORT; CLINICAL FEATURE; DIAGNOSTIC ERROR; DISEASE COURSE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE SYSTEM; MALE; PRIORITY JOURNAL; RETINITIS; UVEITIS;

ADULT; AIDS-RELATED OPPORTUNISTIC INFECTIONS; CYTOMEGALOVIRUS RETINITIS; DIAGNOSTIC ERRORS; HIV INFECTIONS; HUMANS; MALE;

EID: 0346422348     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/380127     Document Type: Article

References (13)

1. Karavellas MP, Plummer DJ, Macdonald JC, et al. Incidence of immune recovery vitritis in cytomegalovirus retinitis patients following institution of successful highly active antiretroviral therapy. J Infect Dis 1999; 179:697-700.
2. Robinson MR, Reed G, Csaky KG, et al. Immune-recovery uveitis in patients with cytomegalovirus retinitis taking highly active antiretroviral therapy. Am J Ophthalmol 2000; 130:49-56.
3. Nguyen QD, Kempen JH, Bolton SG, et al. Immune recovery uveitis in patients with AIDS and cytomegalovirus retinitis after highly active antiretroviral therapy. Am J Ophthalmol 2000; 129:634-9.
4. Jabs DA, Van Natta ML, Kempen JH, et al. Characteristics of patients with cytomegalovirus retinitis in the era of highly active antiretroviral therapy. Am J Ophthalmol 2002; 133:48-61.
5. Sanislo SR, Lowder CY, Kaiser PK. Optic nerve head neovascularization in a patient with inactive cytomegalovirus retinitis and immune recovery. Am J Ophthalmol 1998; 126:318-20.
6. Postelmans L, Payen MC, De Wit S, Caspers-Velu L. Neovascularization of the optic disc after highly active antiretroviral therapy in an AIDS patient with cytomegalovirus retinitis - a new immune recovery-related ocular disorder? Ocul Immunol Inflamm 1999; 7:237-40.
7. Bogie GJ, Nanda SK. Neovascularization associated with cytomegalovirus retinitis. Retina 2001;21:85-7.
8. Wright ME, Suzman DL, Csaky KG, et al. Extensive retinal neovascularization as a late finding in human immunodeficiency virus-infected patients with immune recovery uveitis. Clin Infect Dis 2003; 36:1063-6.
9. Macdonald JC, Karavellas MP, Torriani FJ, et al. Highly active antiretroviral therapy-related immune recovery in AIDS patients with cytomegalovirus retinitis. Ophthalmology 2000; 107:877-81; discussion 81-3.
10. Johnson SC, Benson CA, Johnson DW, Weinberg A. Recurrences of cytomegalovirus retinitis in a human immunodeficiency virus-infected patient, despite potent antiretroviral therapy and apparent immune reconstitution. Clin Infect Dis 2001; 32:815-9.
11. Vinores SA, Youssri AI, Luna JD, et al. Upregulation of vascular endothelial growth factor in ischemic and non-ischemic human and experimental retinal disease. Histol Histopathol 1997; 12:99-109.
12. Karavellas MP, Song M, Macdonald JC, Freeman WR. Long-term posterior and anterior segment complications of immune recovery uveitis associated with cytomegalovirus retinitis. Am J Ophthalmol 2000; 130:57-64.
13. Kim MK, Chan CC, Belfort R Jr, et al. Histopathologic and immunohistopathologic features of subretinal fibrosis and uveitis syndrome. Am J Ophthalmol 1987; 104:15-23.